Navigation Links
Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1

ients."

About Omega DUROS Therapy

Omega DUROS therapy is being developed to improve the treatment of HCV by offering a more convenient and potentially safer and more effective treatment. Omega DUROS therapy is designed to deliver a continuous and consistent dose of omega interferon for three months via the implantable DUROS device, a drug delivery technology developed by ALZA Corporation, and licensed to Intarcia for use in certain broad fields. Another product incorporating the DUROS technology has already approved by the FDA for the palliative treatment of prostate cancer. Intarcia is also leveraging the DUROS technology in evaluating other drug development opportunities. The most advanced of these is focused on the delivery of GLP-1 and a GLP-1 analog with the DUROS device for the treatment of type 2 diabetes.

About Intarcia

Intarcia Therapeutics, Inc. is a biopharmaceutical company developing therapeutics for patients with chronic diseases in which there are significant unmet medical needs. Intarcia's drug development expertise and competitive edge are complemented by its ability to stabilize macromolecules and to deliver them in a constant and consistent manner via the proprietary DUROS drug delivery platform. The initial programs that Intarcia is pursuing are in hepatitis C and type 2 diabetes.

About Hepatitis C

Hepatitis C is a major global public health problem. According to the World Health Organization, more than 170 million people worldwide are chronically infected with HCV, and three to four million new HCV infections occur annually. The U.S. Centers for Disease Control and Prevention has estimated that in the United States approximately 3.4 million people are chronically infected with HCV and approximately 25,000 new patients are infected each year. It is estimated that 10,000 to 12,000 patients die annually in the United States from complications resulting from HCV infection. The current standard of care for tr
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Intarcia Therapeutics Announces Presentation of Final Results From a Phase 2 Combination Study for the Treatment of Hepatitis C at the Digestive Disease Week Conference
2. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
3. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
4. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
5. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
6. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
7. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
8. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
9. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
10. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
11. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics

Post Your Comments:
(Date:11/6/2009)... 6 NexBio Inc., in collaboration w...and Prevention (CDC), St. Louis University, and th...lication of two articles in the peer-reviewed jour... that DAS181 (Fludase ® ) may play a potentia...n of the Pandemic Influenza A(H1N1) and drug-resis...
(Date:11/6/2009)...mber 6 , - Trial Will Com...the,Treatment of Multi-Resistant Staphylococcus Au...ality pharmaceutical company focused on the discov...to overcome the significant global,problem of micr...vanced oral,antibacterial NXL103 (flopristin/linop...
(Date:11/5/2009)... Calif., Nov. 5 Transcep...lty pharmaceutical company focused on the developm...that address important therapeutic needs in the fi...a webcast and teleconference with management to di...sday, November 12, 2009, at 5:00 p.m. Eastern Stan...
Breaking Medicine Technology:NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2New Website www loseadresssize com Launches 53709 1New Website www loseadresssize com Launches 53709 2Pharmacyclics Inc Rights Offering Oversubscribed 13381 1Pharmacyclics Inc Rights Offering Oversubscribed 13381 2Pharmacyclics Inc Rights Offering Oversubscribed 13381 3Winter Park Home to World 26apos 3Bs Foremost Producers of Large Scale Decontamination Equipment 13379 1Winter Park Home to World 26apos 3Bs Foremost Producers of Large Scale Decontamination Equipment 13379 2
... ROCHESTER, Minn., Sept. 25 Mayo Clinic,research...of the more,troubling complications of diabetes --...searchers showed in animal models that a red blood...ecule, normalizing the,digestive process. The find...rnal Gastroenterology ( http://www.gastrojournal.o...
...esults to be Presented at the North American Menop... Meeting, EMERYVILLE, Calif., Sept. 25 Bion...t in a presentation on their new drug,candidate, V... 19th Annual,Meeting of the North American Menopau...08. Dr. Mary Tagliaferri, president and chief medi...
Other Medicine Technology:Mayo Clinic Discovery May Help Diabetic Gastric Problem 2Bionovo's VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness 2Bionovo's VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness 3
(Date:11/8/2009)... of the game later, doctors say , , SUND...he talk of the NFL this season, sidelining such st...llie Parker. , Officials at the American Podiat...diatric Sports Medicine are warning athletes to ta...ike football and lacrosse. , "Many fall sports ...
(Date:11/8/2009)...re-USNewswire/ -- Tonight the House of Representat... Act, landmark health reform legislation that will...rdable, stable and secure health care coverage. Th...surance industry,s worst practices, would extend c...t by $104 billion over ten years. Groups represent...
(Date:11/8/2009)...rying of biopharmaceuticals to be available at the..., Toronto, ON (PRWEB) Nove...of Therapure Biopharma Inc. today announced that t...e pharmaceutical grade freeze dryer and expects to...on) available for contract manufacturing of biopha...
(Date:11/8/2009)...re-USNewswire/ -- Today, the House of Representati...Smith, Ellsworth and Lipinski amendment to the "Af... The amendment maintains the current policy of pre...its packages that include abortion. It clarifies t...ity credits and those who do not, can with their o...
(Date:11/8/2009)...re-USNewswire/ -- USAction this evening hailed pas..., which will make health care more affordable for ...d increase access to health care for millions of A...sevelt, FDR and Harry Truman would be proud," said...vote ranks among our country,s proudest achievemen...
Breaking Medicine News(10 mins):Health News:Rx for Fall Foot Injuries 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2
...duced in the health care system to make doctors mo...nd Minister for Health, Mary Harney said that the ...reasing the number of commoners //on the Medical C...to the behavior of doctors. All this would he...
...ition to the prime minister to increase the suppor... have summoned support from both MPs and actress E...demonstration outside the Department of Health. Th...reastfeed in public in England. They also want the...
..., Andhra Pradesh, Tamil Nadu and Maharashtra are t...stop the rapid spread of Chikungunya.// The diseas...hs of people in the biggest occurrence after it ca... at the meeting. Chikungunya was confined to Kadap...
...ast cancer and vertebral fractures, but raise the ...tudy in the July 13 issue of the New England Journ...ear-long trial of more than 10,000 postmenopausal ...bral fractures and breast cancer, but an increased...
...alth minister E D Marak, who was hospitalised here... today, doctors said. // 'Marak's temparatur... His condition is improving,' Superintendent of st...g from a visit to the Malaria-prone Garo Hills on ...
...baxy Laboratories Ltd today said it had entered in...rtho Inc (JOI) for a generic version of Risperidon... The agreement was signed between Ranbaxy's who...t will provide Ranbaxy with an opportunity to comm...
Other Medicine News:Health News:Risks/Benefits of Osteoporosis Drug Use in Postmenopausal Women 2
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: